. Author manuscript; available in PMC: 2020 May 1.

Published in final edited form as: Optom Vis Sci. 2019 May;96(5):335–344. doi: 10.1097/OPX.0000000000001378

Table 5.

Visual acuity and vision-related outcomes at baseline and 3-week visit for subjects enrolled in the BAM Study.

Visual acuity and vision-related outcomes		Baseline	3-week	P-value
Best-corrected Visual Acuity (logMAR)	High-contrast at Distance	−0.02 ± 0.07	−0.02 ± 0.07	.44
	Low-contrast at Distance	+0.09 ± 0.07	+0.16 ± 0.08	< .0001
	High-contrast at Near	−0.08 ± 0.07	−0.07 ± 0.08	.39
Near Phoria (^∆)^*		−0.5 ± 6.9	−2.7 ± 6.7	.01
Accommodative Lag (D)		1.34 ± 0.45	1.40 ± 0.54	.62
Pupil Size (mm)	Photopic	5.43 ± 0.65	5.40 ± 0.70	.74
Pupil Size (mm)	Mesopic	6.62 ± 0.63	6.58 ± 0.56	.53
Convergence Insufficiency Symptom Survey Score		13.10 ± 7.89	8.55 ± 6.62	< .0001

The subjects wore best-corrected manifest refraction in trial frame for baseline measurements and best-corrected soft bifocal contact lenses for 3-week measurements (pupil size was measured without any corrections in place).

P-value indicates the comparison between baseline and 3-week measurements.

Negative values indicate exophoria